These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30910406)

  • 21. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
    Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.
    Flasche S; Jit M; Rodríguez-Barraquer I; Coudeville L; Recker M; Koelle K; Milne G; Hladish TJ; Perkins TA; Cummings DA; Dorigatti I; Laydon DJ; España G; Kelso J; Longini I; Lourenco J; Pearson CA; Reiner RC; Mier-Y-Terán-Romero L; Vannice K; Ferguson N
    PLoS Med; 2016 Nov; 13(11):e1002181. PubMed ID: 27898668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
    Lee JS; Lourenço J; Gupta S; Farlow A
    Vaccine; 2018 Apr; 36(17):2346-2355. PubMed ID: 29573874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dengue vaccines. A reality for Argentina?].
    Orellano PW; Salomón OD
    Medicina (B Aires); 2016; 76(2):98-102. PubMed ID: 27028058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financing dengue vaccine introduction in the Americas: challenges and opportunities.
    Constenla D; Clark S
    Expert Rev Vaccines; 2016; 15(4):547-59. PubMed ID: 26690087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program].
    Hernández-Ávila M; Lazcano-Ponce E; Hernández-Ávila JE; Alpuche-Aranda CM; Rodríguez-López MH; García-García L; Madrid-Marina V; López Gatell-Ramírez H; Lanz-Mendoza H; Martínez-Barnetche J; Díaz-Ortega JL; Ángeles-Llerenas A; Barrientos-Gutiérrez T; Bautista-Arredondo S; Santos-Preciado JI
    Salud Publica Mex; 2016; 58(1):71-83. PubMed ID: 26879510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil.
    Bärnighausen T; Bloom DE; Cafiero ET; O'Brien JC
    Semin Immunol; 2013 Apr; 25(2):104-13. PubMed ID: 23886895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean.
    Takemoto ML; Bahia L; Toscano CM; Araujo DV
    Vaccine; 2013 Jul; 31 Suppl 3():C45-57. PubMed ID: 23777691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.
    Lim JK; Lee YS; Wilder-Smith A; Thiry G; Mahoney R; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):529-38. PubMed ID: 26651238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies.
    de Soarez PC; Martins Rozman L; Siraisi Fonseca T; Rodrigo Borsari P; Percio J; Guzmán Barrera LS; Christovam Sartori AM
    Vaccine; 2023 Feb; 41(7):1319-1332. PubMed ID: 36707337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
    Orellano PW; Reynoso JI; Stahl HC; Salomon OD
    Vaccine; 2016 Jan; 34(5):616-621. PubMed ID: 26724542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness and budget impact analyses of dengue vaccination in Indonesia.
    Suwantika AA; Supadmi W; Ali M; Abdulah R
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009664. PubMed ID: 34383764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis.
    Chang E; Li H; Zheng W; Zhou L; Jia Y; Gu W; Cao Y; Zhu X; Xu J; Liu B; You M; Liu K; Wang M; Huang W
    Appl Health Econ Health Policy; 2024 Jul; 22(4):457-470. PubMed ID: 38598091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in reducing dengue burden; diagnostics, control measures and vaccines.
    Lam SK
    Expert Rev Vaccines; 2013 Sep; 12(9):995-1010. PubMed ID: 24053394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model.
    Shim E
    PLoS One; 2017; 12(4):e0175020. PubMed ID: 28380060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brazil's dengue vaccine campaign falters.
    Triunfol M
    Lancet Infect Dis; 2024 Jun; 24(6):e358. PubMed ID: 38795726
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
    Lam SK; Burke D; Capeding MR; Chong CK; Coudeville L; Farrar J; Gubler D; Hadinegoro SR; Hanna J; Lang J; Lee HL; Leo YS; Luong CQ; Mahoney R; McBride J; Mendez-Galvan J; Ng LC; Nimmannitya S; Ooi EE; Shepard D; Smit J; Teyssou R; Thomas L; Torresi J; Vasconcelos P; Wirawan DN; Yoksan S
    Vaccine; 2011 Nov; 29(51):9417-22. PubMed ID: 21864627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
    Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
    Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
    Coudeville L; Baurin N; L'Azou M; Guy B
    Vaccine; 2016 Dec; 34(50):6426-6435. PubMed ID: 27601343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.